The @entity5011 : XXXX .

@entity1 @entity4094 @entity129 @entity55 @entity16 @entity358 @entity5011 @entity221
In a retrospective analysis of 40 hospitalized @entity1 with the @entity5011 ( @entity5011 ), we related the use and outcome of assisted ventilation to specific quantitative details of the @entity16 . Two @entity1 had an unusually prolonged course: they were ventilated for 374 and 396 days before successful weaning. The other 38 @entity1 were similar in most respects to those in previously reported series. Sixteen ventilated @entity1 were hospitalized 56.6 +/- 10.6 (mean +/- S.E.M.) days, were ventilated 27.9 +/- 6.5 days, and had primarily @entity358 . There were 4 deaths during ventilation, and 9 of 13 survivors (69%) had a short-term excellent functional neurologic outcome. Attention to the neurologic details of the course of @entity221 may spare some @entity1 from tracheostomy. Twenty-two @entity1 not requiring respirator support suffered distinctly less severe @entity4094 with @entity129 , had no occurrence of @entity55 , and were discharged after 19.1 +/- 4.6 days. Eighty-one percent had an excellent functional outcome. The wide range of manifestations and severity of @entity1 with @entity5011 requires the attending physician to be flexible in dealing with each case and not make management decisions arbitrarily, by reference to a hypothetical "typical case."
